enVVeno Medical Corp Total Liabilities and Equity
enVVeno Medical Corp (NVNO) had Total Liabilities and Equity of $22.66 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-07-30
- 2026-06-30: Liabilities and Equity $22.66M.
- 2026-03-31: Liabilities and Equity $26.10M.
- 2025-12-31: Liabilities and Equity $29.56M.
- 2025-09-30: Liabilities and Equity $32.35M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $22.66M 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $26.10M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $29.56M 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $32.35M 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $36.58M 10-Q · filed 2025-07-31 | |
| 2025-03-31 | $40.58M 10-Q · filed 2025-04-30 | |
| 2024-12-31 | $44.95M 10-K · filed 2026-03-26 | |
| 2024-09-30 | $50.39M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $40.99M 10-Q · filed 2024-07-31 | |
| 2024-03-31 | $44.83M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $48.63M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $28.09M 10-Q · filed 2023-10-26 | |
| 2023-06-30 | $32.09M 10-Q · filed 2023-07-31 | |
| 2023-03-31 | $36.61M 10-Q · filed 2023-04-28 | |
| 2022-12-31 | $41.66M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $45.46M 10-Q · filed 2022-10-27 | |
| 2022-06-30 | $49.93M 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $54.22M 10-Q · filed 2022-04-29 | |
| 2021-12-31 | $57.70M 10-K · filed 2023-03-02 | $57.70M 10-K · filed 2022-03-28 |
| 2021-09-30 | $59.17M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $42.35M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $45.05M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $10.54M 10-K · filed 2022-03-28 | |
| 2020-09-30 | $7.04M 10-Q · filed 2020-11-17 | |
| 2020-06-30 | $3.73M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $2.77M 10-Q · filed 2020-06-08 | |
| 2019-12-31 | $3.43M 10-K · filed 2021-03-31 | |
| 2019-09-30 | $5.75M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $7.25M 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $5.49M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $3.56M 10-K · filed 2020-03-18 | |
| 2018-09-30 | $5.44M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $7.21M 10-Q · filed 2018-08-10 | |
| 2017-12-31 | $2.21M 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |